Literature DB >> 26041282

New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.

Lucie Fénéant1, Julie Potel1, Catherine François2, Famara Sané3, Florian Douam4, Sandrine Belouzard1, Noémie Calland1, Thibaut Vausselin1, Yves Rouillé1, Véronique Descamps2, Thomas F Baumert5, Gilles Duverlie2, Dimitri Lavillette4, Didier Hober3, Jean Dubuisson1, Czeslaw Wychowski1, Laurence Cocquerel6.   

Abstract

UNLABELLED: In our study, we characterized the effect of monensin, an ionophore that is known to raise the intracellular pH, on the hepatitis C virus (HCV) life cycle. We showed that monensin inhibits HCV entry in a pangenotypic and dose-dependent manner. Monensin induces an alkalization of intracellular organelles, leading to an inhibition of the fusion step between viral and cellular membranes. Interestingly, we demonstrated that HCV cell-to-cell transmission is dependent on the vesicular pH. Using the selective pressure of monensin, we selected a monensin-resistant virus which has evolved to use a new entry route that is partially pH and clathrin independent. Characterization of this mutant led to the identification of two mutations in envelope proteins, the Y297H mutation in E1 and the I399T mutation in hypervariable region 1 (HVR1) of E2, which confer resistance to monensin and thus allow HCV to use a pH-independent entry route. Interestingly, the I399T mutation introduces an N-glycosylation site within HVR1 and increases the density of virions and their sensitivity to neutralization with anti-apolipoprotein E (anti-ApoE) antibodies, suggesting that this mutation likely induces conformational changes in HVR1 that in turn modulate the association with ApoE. Strikingly, the I399T mutation dramatically reduces HCV cell-to-cell spread. In summary, we identified a mutation in HVR1 that overcomes the vesicular pH dependence, modifies the biophysical properties of particles, and drastically reduces cell-to-cell transmission, indicating that the regulation by HVR1 of particle association with ApoE might control the pH dependence of cell-free and cell-to-cell transmission. Thus, HVR1 and ApoE are critical regulators of HCV propagation. IMPORTANCE: Although several cell surface proteins have been identified as entry factors for hepatitis C virus (HCV), the precise mechanisms regulating its transmission to hepatic cells are still unclear. In our study, we used monensin A, an ionophore that is known to raise the intracellular pH, and demonstrated that cell-free and cell-to-cell transmission pathways are both pH-dependent processes. We generated monensin-resistant viruses that displayed different entry routes and biophysical properties. Thanks to these mutants, we highlighted the importance of hypervariable region 1 (HVR1) of the E2 envelope protein for the association of particles with apolipoprotein E, which in turn might control the pH dependency of cell-free and cell-to-cell transmission.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26041282      PMCID: PMC4524216          DOI: 10.1128/JVI.00192-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

1.  Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins.

Authors:  David Delgrange; André Pillez; Sandrine Castelain; Laurence Cocquerel; Yves Rouillé; Jean Dubuisson; Takaji Wakita; Gilles Duverlie; Czeslaw Wychowski
Journal:  J Gen Virol       Date:  2007-09       Impact factor: 3.891

2.  Hepatitis C virus entry depends on clathrin-mediated endocytosis.

Authors:  Emmanuelle Blanchard; Sandrine Belouzard; Lucie Goueslain; Takaji Wakita; Jean Dubuisson; Czeslaw Wychowski; Yves Rouillé
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

4.  Robust hepatitis C virus infection in vitro.

Authors:  Jin Zhong; Pablo Gastaminza; Guofeng Cheng; Sharookh Kapadia; Takanobu Kato; Dennis R Burton; Stefan F Wieland; Susan L Uprichard; Takaji Wakita; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

5.  Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses.

Authors:  George Koutsoudakis; Artur Kaul; Eike Steinmann; Stephanie Kallis; Volker Lohmann; Thomas Pietschmann; Ralf Bartenschlager
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles.

Authors:  Laurent Meertens; Claire Bertaux; Tatjana Dragic
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

7.  Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.

Authors:  Dimitri Lavillette; Eve-Isabelle Pécheur; Peggy Donot; Judith Fresquet; Jennifer Molle; Romuald Corbau; Marlène Dreux; François Penin; François-Loïc Cosset
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

8.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

9.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Authors:  Matthew J Evans; Thomas von Hahn; Donna M Tscherne; Andrew J Syder; Maryline Panis; Benno Wölk; Theodora Hatziioannou; Jane A McKeating; Paul D Bieniasz; Charles M Rice
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

10.  Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry.

Authors:  Donna M Tscherne; Christopher T Jones; Matthew J Evans; Brett D Lindenbach; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

View more
  10 in total

1.  Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.

Authors:  Thibaut Vausselin; Karin Séron; Muriel Lavie; Ahmed Atef Mesalam; Matthieu Lemasson; Sandrine Belouzard; Lucie Fénéant; Adeline Danneels; Yves Rouillé; Laurence Cocquerel; Lander Foquet; Arielle R Rosenberg; Czeslaw Wychowski; Philip Meuleman; Patricia Melnyk; Jean Dubuisson
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

2.  Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.

Authors:  Fanfan Zhao; Ting Zhao; Libin Deng; Dawei Lv; Xiaolong Zhang; Xiaoyu Pan; Jun Xu; Gang Long
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

Review 3.  Protons to Patients: targeting endosomal Na+ /H+ exchangers against COVID-19 and other viral diseases.

Authors:  Hari Prasad
Journal:  FEBS J       Date:  2021-09       Impact factor: 5.622

4.  A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.

Authors:  Myungeun Lee; Jaewon Yang; Eunji Jo; Ji-Young Lee; Hee-Young Kim; Ralf Bartenschlager; Eui-Cheol Shin; Yong-Soo Bae; Marc P Windisch
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

Review 5.  Hepatitis C Virus Glycan-Dependent Interactions and the Potential for Novel Preventative Strategies.

Authors:  Emmanuelle V LeBlanc; Youjin Kim; Chantelle J Capicciotti; Che C Colpitts
Journal:  Pathogens       Date:  2021-06-01

Review 6.  Fusion of Enveloped Viruses in Endosomes.

Authors:  Judith M White; Gary R Whittaker
Journal:  Traffic       Date:  2016-04-07       Impact factor: 6.215

Review 7.  Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.

Authors:  Muriel Lavie; Xavier Hanoulle; Jean Dubuisson
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

8.  (+)-Catechin inhibition of transmissible gastroenteritis coronavirus in swine testicular cells is involved its antioxidation.

Authors:  Wulong Liang; Lei He; Pengbo Ning; Jihui Lin; Helin Li; Zhi Lin; Kai Kang; Yanming Zhang
Journal:  Res Vet Sci       Date:  2015-09-12       Impact factor: 2.534

Review 9.  HCV Interplay with Lipoproteins: Inside or Outside the Cells?

Authors:  François-Loïc Cosset; Chloé Mialon; Bertrand Boson; Christelle Granier; Solène Denolly
Journal:  Viruses       Date:  2020-04-12       Impact factor: 5.048

10.  Release of Infectious Hepatitis C Virus from Huh7 Cells Occurs via a trans-Golgi Network-to-Endosome Pathway Independent of Very-Low-Density Lipoprotein Secretion.

Authors:  Jamel Mankouri; Cheryl Walter; Hazel Stewart; Matthew Bentham; Wei Sun Park; Won Do Heo; Mitsunori Fukuda; Stephen Griffin; Mark Harris
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.